In This Store
Category:Active Pharmaceutical Ingredients > Antibiotics > Other Antibiotics
Product Name:TYLVALOSIN TARTRATE
CAS No.:63428-13-7
Standard:ChP, USP, BP, EP, JP, In-house Standards
Price(USD):0.00
Company:Shandong Shengli Bioengineering
Grade: Veterinary Grade
Factory Location: JINING, SHANDONG, CHINA
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East
Monthly Production Capacity: 120TON
Packaging Information: 10KG/FIBER DRUM
Sample Provided: no
(4R,5S,6S,7R,9R,11E,13E,15R,16R)-15-(((6-Deoxy-2,3-di-O-methyl-beta-D-allopyranosyl)oxy)methyl)-6-((3,6-dideoxy-4-O-(2,6-dideoxy-3-C-methyl-4-O-(3-methylbutanoyl)-alpha-L-ribo-hexopyranosyl)-3-(dimethylamino)-beta-D-glucopyranosyl)oxy)-16-ethyl-5,9,13-trimethyl-2,10-dioxo-7-(2-oxoethyl)oxacyclohexadeca-11,13-dien-4-yl acetate(2R,3R)-2,3-dihydroxybutan edioate.
Tylvalosin (acetylisovaleryltylosin) tartrate, although a relatively new macrolide antibiotic, is currently successfully used in many countries of the world for the treatment and control of the major mycoplasmal infections such as chronic respiratory disease (CRD) and infectious synovitis in poultry.
Tylvalosin is up to 8 times more active in-vitro than tylosin against Mycoplasma gallisepticum & M.synoviae, is 3 times better absorbed, and also concentrates in target tissues. It is thus a powerful treatment for mycoplasmosis at a quarter the dose of tylosin. Furthermore Tylvalosin is effective against Mycoplasma strains resistant to tylosin and other macrolides.
Tylvalosin also shows strong activity against, Clostridium perfringens, the causal organism of Necrotic Enteritis in poultry. Now, in two new trials, it has shown extremely promising in vitro activity against Ornithobacterium rhinotracheale (ORT), an organism that is an important cause of respiratory disease in poultry.
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us: